Combined drug therapy in gastrointestinal disturbances; increased benefit through diminished side reactions.
D004359:Drug Therapy, Combination; D005767:Gastrointestinal Diseases / Q000628:therapy*; D006801:Humans; D008620:Meprobamate / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000628:therapy*
D010276:Parasympatholytics; D008620:Meprobamate
GASTROINTESTINAL DISEASES/therapy; MEPROBAMATE/therapeutic use; PARASYMPATHOLYTICS/therapeutic use; PEPTIC ULCER/therapy